Comparative study of Oral Nutritional Supplements vs Intralesional Triamcinolone and Hyaluronidase in Oral Submucous Fibrosis

  • Dr Reema Goswami Assistant Professor, Department of E.N.T, Bundelkhand Medical College Sagar, MP, India
  • Dr.Amar Gangwani Assistant Professor Department of Pathology, Bundelkhand Medical College Sagar, MP, India
  • Dr Shweta Bhatnagar Assistant Professor, Department of Dentistry, Bundelkhand Medical College Sagar, MP, India
  • Dr Deepti Singh Senior Resident, Department of ENT, Bundelkhand Medical College Sagar, MP, India
Keywords: Oral submucous fibrosis, Triamcinolone acetonide, Hyaluronidase, Lycopene, Premalignant condition, Interincisal distance

Abstract

Introduction: Oral submucous fibrosis (OSMF) is a common premalignant condition found in Indian subcontinent caused by chewing arecanut, betel quid and gutkha with tobacco. A standard treatment to manage this condition is not yet available. The various modalities of treatment are nutritional oral antioxidants, intralesional injections, and surgical removal of bands. We compared the efficacy of intraoral administration of vitamin B combined with lycopene with intralesional triamcinolone acetonide combined with hyaluronidase and oral vitamin B complex with lycopene.

Methods: 80 patients suffering from OSMF diagnosed clinically were treated in Bundlekhand Medical College Sagar for 4 months. The patients were divided into two groups randomly. Group A patients received oral administration of vitamin B complex, lycopene and topical triamcinolone for 4 months. Group B received weekly intralesional injections of triamcinolone combined with hyaluronidase for 8 weeks along with vitamin B complex, lycopene and topical triamcinolone for 4 months. Treatment outcome was evaluated on the basis of improvement in mouth opening, decrease in burning sensation and healing of ulceration.

Result: Group B patients receiving intralesional injections of triamcinolone and hyaluronidase along with nutritional supplements showed improvement in degree of trismus as well as burning sensation and ulceration as compared to Group A receiving only nutritional supplements.

Conclusion: Intralesional injection of triamcinolone combined with hyaluronidase with oral antioxidants is more effective in treating the patients with OSMF than antioxidants alone. No side effects were seen in both the groups though some patients complained of pain during administration of injection.

Downloads

Download data is not yet available.

References

1. Cannif JP, Harvey W, Harris M. Oral submous fibrosis: its pathogenesis and management. Br Dent J.1986; 160(12):429- 34. [PubMed]

2. Gupta PC, Sinor PN, Bhonsle RB, Pawar VS, Metha HC. Oral submucous fibrosis in India. A new epidemic? Natl Med J India.1998 May-June; 11(3):113-6. [PubMed]

3. Ahmad MS, Ali SA, Ali AS, Chaubey KK. Epidemiological and etiological study of oral submucous fibrosis among gutkha chewers of Patna, Bihar, India .J Indian Soc Pedod Prev Den. 2006 June; 24(2): 84-9. [PubMed]

4. Pindborg JJ, Sirsat SM. Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol.1966Dec; 22(6): 764-79. [PubMed]

5. Pindborg JJ, Metha FS, Daftary DK. Occurrence of epithelial atypia in 51 Indian villagers with oral submucous fibrosis. Br J Cancer1970 June; 24(2); 253-7. [PubMed]

6. Maher R, Lee AJ, Warnakulasuriya, KA, Lewis JA, Johnson NW. Role of areca nut in causation of oral submucous fibrosis: a case control study in Pakistan. J. Oral Pathol Med.1994 Feb; 23(2); 65-9. [PubMed]

7. Babu S, Sesikaran B, Bhat RV. Oral fibrosis among teenagers chewing tobacco, areca nut and pan masala.Lancet.1996 Sep 7;348(9028): 692. [PubMed]

8. MartinH, Koop EC. Precancerous mouth lesions of avitaminosis B: their aetiology, response to therapy and relationship to intraoral cancer. Am J Surg. 1942; 57: 195. [PubMed]

9. Kumar A. Efficacy of lycopene in management of oral submucous fibrosis. Oral Surgery,Oral medicine, Oral Pathology, Oral Radiol Endod .2007;103:214-15. [PubMed]

10. Karkar PK, Puri RK,,Venkatachalam VP. Oral submucous fibrosis treatment with hyalase. J Laryngol Otol.1985 Jan; 99(1):57-9. [PubMed]

11. Lai DR, Chen HR, Lin LM, Huang YL, Tsai CC. Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases. J Oral Pathol Med. 1995 Oct; 24(9):402-6. [PubMed]

12. Borle RM, Borle SR. Management of oral submous fibrosis: A conservative approach. J Oral Maxillofac Surg 1991Aug; 49(8); 788-91. [PubMed]

13. Khanna JN, Andrade NN. Oral submucous fibrosis: A new concept in surgical management. Report of 100 cases. J Oral Maxillofac Surg. 1995 Dec; 24(6):433-9. [PubMed]
14. Gupta D, Sharma SC. Oral submucous fibrosis - a new treatment regimen. J Oral Maxillofac Surg.1988 Oct; 46(10):830-3. [PubMed]


15. Samman N, Cheung LK, Tideman H. The buccal fat pad in oral reconstruction. Int J Oral Maxillofac Surg.1993Feb; 22(1):2- 6. [PubMed]

16. Tideman H, Bosanquet A, Scott J. Use of the buccal fat pad as a pedicled graft. J Oral Maxillofac Surg. 1986 Jun; 44(6):435- 40. [PubMed]

17. Dino BR, Eufemio GG, De Villa MS. Human amnion; the establishment of an amnion bank and its practical applications in surgery. J Philipp Med Assoc.1965Jul; 42(7):357-66. [PubMed]

18. Frame JW. Carbon dioxide laser surgery for benign oral lesions. Br Dent J.1985 Feb; 158(4):125-8. [PubMed]

19. Strong MS, Jako GJ, Polanyi T, Wallace RA. Laser surgery in the aerodigestive tract. Am J Surg.1973 Oct; 126(4):529-33. [PubMed]
Comparative study of Oral Nutritional Supplements vs Intralesional Triamcinolone and Hyaluronidase in Oral Submucous Fibrosis
CITATION
DOI: 10.17511/ijmrr.2014.i02.08
Published: 2014-04-30
How to Cite
1.
Goswami R, Gangwani A, Bhatnagar S, Singh D. Comparative study of Oral Nutritional Supplements vs Intralesional Triamcinolone and Hyaluronidase in Oral Submucous Fibrosis. Int J Med Res Rev [Internet]. 2014Apr.30 [cited 2024Jul.3];2(2):114-8. Available from: https://ijmrr.medresearch.in/index.php/ijmrr/article/view/71
Section
Original Article